Brown Brothers Harriman & Co Has Decreased By $20.77 Million Its Us Bancorp (USB) Position; Incyte Genomics (INCY) Sellers Increased By 14.31% Their Shorts

January 18, 2018 - By Marie Mckinney

Brown Brothers Harriman & Co decreased Us Bancorp (USB) stake by 2% reported in 2017Q3 SEC filing. Brown Brothers Harriman & Co sold 391,848 shares as Us Bancorp (USB)’s stock declined 6.89%. The Brown Brothers Harriman & Co holds 19.16M shares with $1.03B value, down from 19.55 million last quarter. Us Bancorp now has $93.18B valuation. The stock decreased 0.34% or $0.19 during the last trading session, reaching $56.15. About 8.75M shares traded or 53.71% up from the average. U.S. Bancorp (NYSE:USB) has risen 23.07% since January 18, 2017 and is uptrending. It has outperformed by 6.37% the S&P500.

Incyte Genomics Incorporated (NASDAQ:INCY) had an increase of 14.31% in short interest. INCY’s SI was 6.97M shares in January as released by FINRA. Its up 14.31% from 6.10 million shares previously. With 1.58 million avg volume, 4 days are for Incyte Genomics Incorporated (NASDAQ:INCY)’s short sellers to cover INCY’s short positions. The SI to Incyte Genomics Incorporated’s float is 4.45%. The stock increased 1.78% or $1.61 during the last trading session, reaching $91.92. About 1.68M shares traded. Incyte Corporation (NASDAQ:INCY) has risen 72.84% since January 18, 2017 and is uptrending. It has outperformed by 56.14% the S&P500.

Among 30 analysts covering U.S. Bancorp (NYSE:USB), 8 have Buy rating, 2 Sell and 20 Hold. Therefore 27% are positive. U.S. Bancorp had 79 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of U.S. Bancorp (NYSE:USB) earned “Hold” rating by Susquehanna on Thursday, January 4. The stock of U.S. Bancorp (NYSE:USB) earned “Overweight” rating by Barclays Capital on Tuesday, January 3. The rating was downgraded by Atlantic Securities on Wednesday, December 21 to “Neutral”. Jefferies maintained the stock with “Buy” rating in Friday, August 11 report. The rating was downgraded by Bank of America on Monday, October 2 to “Sell”. Piper Jaffray initiated the stock with “Overweight” rating in Tuesday, November 24 report. The rating was upgraded by Jefferies to “Buy” on Monday, November 28. The firm earned “Hold” rating on Thursday, April 20 by Rafferty. As per Friday, January 5, the company rating was upgraded by PiperJaffray. The company was maintained on Tuesday, June 13 by Keefe Bruyette & Woods.

Since August 9, 2017, it had 0 buys, and 1 insider sale for $15,927 activity. $15,927 worth of U.S. Bancorp (NYSE:USB) was sold by Gifford Craig E.

Investors sentiment decreased to 0.89 in 2017 Q3. Its down 0.01, from 0.9 in 2017Q2. It turned negative, as 61 investors sold USB shares while 441 reduced holdings. 81 funds opened positions while 368 raised stakes. 1.20 billion shares or 1.15% less from 1.21 billion shares in 2017Q2 were reported. 20,790 were reported by Mitchell Mcleod Pugh & Williams Inc. Legacy Cap Ptnrs holds 14,179 shares. Macguire Cheswick And Tuttle Inv Counsel Limited Liability stated it has 65,827 shares or 0.69% of all its holdings. North Star Investment Mgmt has 28,667 shares for 0.19% of their portfolio. Signaturefd Limited Liability Corp reported 0.05% stake. Advisor Ptnrs owns 38,210 shares. 21,591 were reported by Mraz Amerine And Assoc. Seaward Management Ltd Partnership has invested 0.09% in U.S. Bancorp (NYSE:USB). Provise Mngmt Gp reported 0.24% in U.S. Bancorp (NYSE:USB). 3.44 million are owned by Grantham Mayo Van Otterloo Lc. Zacks Investment Management reported 0.95% stake. Sentry Investments reported 0.51% of its portfolio in U.S. Bancorp (NYSE:USB). Lowe Brockenbrough Inc reported 0.29% in U.S. Bancorp (NYSE:USB). Hirtle Callaghan And Ltd Limited Liability Company stated it has 440 shares. Yacktman Asset Mngmt Ltd Partnership holds 2.55% or 4.93 million shares in its portfolio.

Brown Brothers Harriman & Co increased Wells Fargo & Co (NYSE:WFC) stake by 111,341 shares to 18.32M valued at $1.01 billion in 2017Q3. It also upped Ishares Core S&P 500 Etf (IVV) stake by 1,753 shares and now owns 56,344 shares. Mohawk Industries Inc (NYSE:MHK) was raised too.

Since August 1, 2017, it had 1 insider buy, and 9 insider sales for $325,377 activity. Stein Steven H sold 2,111 shares worth $263,875. Siegel Eric H. had sold 1,820 shares worth $241,914 on Tuesday, August 1. Shares for $375,750 were sold by Trower Paul. Flannelly Barry P had sold 714 shares worth $88,715 on Wednesday, September 13. BAKER BROS. ADVISORS LP also bought $13.20M worth of Incyte Corporation (NASDAQ:INCY) on Friday, September 8. Another trade for 20,000 shares valued at $2.80 million was sold by SWAIN PAULA J. $668,361 worth of Incyte Corporation (NASDAQ:INCY) was sold by GRYSKA DAVID W.

Investors sentiment increased to 1.04 in 2017 Q3. Its up 0.02, from 1.02 in 2017Q2. It improved, as 39 investors sold Incyte Corporation shares while 161 reduced holdings. 59 funds opened positions while 149 raised stakes. 188.97 million shares or 2.28% more from 184.77 million shares in 2017Q2 were reported. Mutual Of America Cap Mgmt Lc stated it has 21,398 shares or 0.04% of all its holdings. Fifth Third Bancshares has 270 shares. Great West Life Assurance Can stated it has 0.03% of its portfolio in Incyte Corporation (NASDAQ:INCY). 75,004 were accumulated by Korea Investment Corporation. British Columbia Inv Mngmt owns 70,339 shares or 0.06% of their US portfolio. Efg Asset Mgmt (Americas) holds 0.19% or 4,312 shares in its portfolio. State Of Tennessee Treasury Department has 0.03% invested in Incyte Corporation (NASDAQ:INCY). Maryland-based Profund Llc has invested 0.41% in Incyte Corporation (NASDAQ:INCY). Exxonmobil Investment Management Tx holds 0.09% or 31,179 shares. Pub Sector Pension Inv Board owns 18,635 shares. Keybank Natl Association Oh accumulated 8,384 shares. Clarivest Asset Management Limited Company invested 0% in Incyte Corporation (NASDAQ:INCY). Parametric Assocs Ltd Com has invested 0.03% in Incyte Corporation (NASDAQ:INCY). Grandfield Dodd Limited Liability holds 7,798 shares or 0.1% of its portfolio. Tekla Capital Mgmt Ltd Liability holds 693,275 shares or 2.89% of its portfolio.

Among 24 analysts covering Incyte (NASDAQ:INCY), 20 have Buy rating, 0 Sell and 4 Hold. Therefore 83% are positive. Incyte had 75 analyst reports since August 6, 2015 according to SRatingsIntel. Credit Suisse initiated the shares of INCY in report on Wednesday, January 20 with “Outperform” rating. SunTrust maintained it with “Buy” rating and $155.0 target in Tuesday, October 31 report. RBC Capital Markets maintained Incyte Corporation (NASDAQ:INCY) on Wednesday, October 12 with “Outperform” rating. The firm earned “Buy” rating on Wednesday, August 5 by UBS. The company was upgraded on Thursday, September 29 by Raymond James. Suntrust Robinson initiated Incyte Corporation (NASDAQ:INCY) on Friday, August 5 with “Buy” rating. The firm earned “Outperform” rating on Monday, November 9 by Oppenheimer. The company was upgraded on Tuesday, January 2 by RBC Capital Markets. On Tuesday, July 25 the stock rating was maintained by Oppenheimer with “Hold”. J.P. Morgan maintained Incyte Corporation (NASDAQ:INCY) on Tuesday, August 1 with “Buy” rating.

Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally. The company has market cap of $19.40 billion. It offers JAKAFI for the treatment of myelofibrosis and polycythemia vera cancers. It currently has negative earnings. The companyÂ’s clinical stage products include ruxolitinib cream that is in Phase II clinical trial for the treatment of alopecia areata and atopic dermatitis; and baricitinib, which is in Phase III clinical trial for treatment of rheumatoid arthritis.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: